Krystal Biotech, Inc. (KRYS)
341.78
-4.80
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
341.78
0.00 (0.00%)
After-Hours: 19:20
Krystal Biotech Debt to Equity Ratio : 0.0065 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0065 |
| March 31, 2026 | 0.0071 |
| December 31, 2025 | 0.0077 |
| September 30, 2025 | 0.0084 |
| June 30, 2025 | 0.0093 |
| March 31, 2025 | 0.0098 |
| December 31, 2024 | 0.0077 |
| September 30, 2024 | 0.0084 |
| June 30, 2024 | 0.0092 |
| March 31, 2024 | 0.0099 |
| December 31, 2023 | 0.0104 |
| September 30, 2023 | 0.011 |
| June 30, 2023 | 0.0131 |
| March 31, 2023 | 0.0179 |
| December 31, 2022 | 0.0171 |
| September 30, 2022 | 0.0169 |
| June 30, 2022 | 0.0163 |
| March 31, 2022 | 0.0169 |
| December 31, 2021 | 0.0135 |
| September 30, 2021 | 0.0198 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0187 |
| March 31, 2021 | 0.009 |
| December 31, 2020 | 0.0395 |
| September 30, 2020 | 0.0103 |
| June 30, 2020 | 0.0102 |
| March 31, 2020 | 0.0162 |
| December 31, 2019 | 0.0161 |
| September 30, 2019 | 0.016 |
| June 30, 2019 | 0.017 |
| March 31, 2019 | 0.031 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -4.996 |
| March 31, 2017 | -18.80 |
| December 31, 2016 | 6.377 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| TG Therapeutics, Inc. | 1.249 |
| Tenaya Therapeutics, Inc. | 0.0569 |
| Cytokinetics, Inc. | -7.324 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.501B |
| Total Liabilities (Quarterly) | 141.52M |
| Shareholders Equity (Quarterly) | 1.359B |
| Current Ratio | 8.318 |
| Net Debt Paydown Yield | 0.00% |